Fenugreek Supplement Capsules Recalled for Pen Pieces Contamination
Vitality Works is recalling 1,025 bottles of 600mg Fenugreek Capsules due to contamination with pen pieces. The affected lot is 2023-06871, expiring July 2028.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is classified as an FDA Class II recall for foreign material contamination. Although no illnesses or injuries have been reported, the presence of pen pieces in consumed capsules poses a potential choking and injury hazard, meeting the High severity threshold for risk-of-harm products without reported harm.
Plain-English summary
Vitality Works, Inc. is recalling certain Fenugreek Capsules (600mg, 90 count) because pieces of a pen have been found in the product as a contaminant.
The recall affects approximately 1,025 bottles that were distributed to 55 retail customers across 284 individual stores in the United States. No distribution occurred to foreign countries or US Government agencies. The affected lot is 2023-06871, which expires in July 2028.
Consumers who have purchased the recalled product should stop using it immediately and return it to the store where it was purchased. The pen pieces present a potential choking and injury hazard if ingested.
The recalled product
- Product
- 100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap.
- Manufacturer
- Vitality Works, Inc
- Category
- Drug — Dietary Supplement
- Hazard
- foreign-material
- choking
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27